279 related articles for article (PubMed ID: 25724000)
1. Sox10--a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors.
Miettinen M; McCue PA; Sarlomo-Rikala M; Biernat W; Czapiewski P; Kopczynski J; Thompson LD; Lasota J; Wang Z; Fetsch JF
Am J Surg Pathol; 2015 Jun; 39(6):826-35. PubMed ID: 25724000
[TBL] [Abstract][Full Text] [Related]
2. Sox10: a pan-schwannian and melanocytic marker.
Nonaka D; Chiriboga L; Rubin BP
Am J Surg Pathol; 2008 Sep; 32(9):1291-8. PubMed ID: 18636017
[TBL] [Abstract][Full Text] [Related]
3. Sox10 and S100 in the diagnosis of soft-tissue neoplasms.
Karamchandani JR; Nielsen TO; van de Rijn M; West RB
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):445-50. PubMed ID: 22495377
[TBL] [Abstract][Full Text] [Related]
4. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
[TBL] [Abstract][Full Text] [Related]
5. A newly developed mouse monoclonal SOX10 antibody is a highly sensitive and specific marker for malignant melanoma, including spindle cell and desmoplastic melanomas.
Tacha D; Qi W; Ra S; Bremer R; Yu C; Chu J; Hoang L; Robbins B
Arch Pathol Lab Med; 2015 Apr; 139(4):530-6. PubMed ID: 25436903
[TBL] [Abstract][Full Text] [Related]
6. SOX10 expression in mammary invasive ductal carcinomas and benign breast tissue.
Chiu K; Ionescu DN; Hayes M
Virchows Arch; 2019 Jun; 474(6):667-672. PubMed ID: 30903273
[TBL] [Abstract][Full Text] [Related]
7. SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis.
Ohtomo R; Mori T; Shibata S; Tsuta K; Maeshima AM; Akazawa C; Watabe Y; Honda K; Yamada T; Yoshimoto S; Asai M; Okano H; Kanai Y; Tsuda H
Mod Pathol; 2013 Aug; 26(8):1041-50. PubMed ID: 23558573
[TBL] [Abstract][Full Text] [Related]
8. Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters.
Hornick JL; Fletcher CD
Am J Surg Pathol; 2003 Sep; 27(9):1183-96. PubMed ID: 12960802
[TBL] [Abstract][Full Text] [Related]
9. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma.
Hsieh MS; Lee YH; Chang YL
Hum Pathol; 2016 Oct; 56():134-42. PubMed ID: 27327192
[TBL] [Abstract][Full Text] [Related]
10. SOX10/keratin dual-color immunohistochemistry: An effective first-line test for the workup of epithelioid malignant neoplasms in FNA and small biopsy specimens.
Mito JK; Conner JR; Hornick JL; Cibas ES; Qian X
Cancer Cytopathol; 2018 Mar; 126(3):179-189. PubMed ID: 29385322
[TBL] [Abstract][Full Text] [Related]
11. p63 immunohistochemical staining is limited in soft tissue tumors.
Jo VY; Fletcher CD
Am J Clin Pathol; 2011 Nov; 136(5):762-6. PubMed ID: 22031315
[TBL] [Abstract][Full Text] [Related]
12. Utility of Sox10 labeling in metastatic breast carcinomas.
Nelson ER; Sharma R; Argani P; Cimino-Mathews A
Hum Pathol; 2017 Sep; 67():205-210. PubMed ID: 28843711
[TBL] [Abstract][Full Text] [Related]
13. Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas.
Cimino-Mathews A; Subhawong AP; Elwood H; Warzecha HN; Sharma R; Park BH; Taube JM; Illei PB; Argani P
Hum Pathol; 2013 Jun; 44(6):959-65. PubMed ID: 23260325
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic utility of SOX10 to distinguish malignant peripheral nerve sheath tumor from synovial sarcoma, including intraneural synovial sarcoma.
Kang Y; Pekmezci M; Folpe AL; Ersen A; Horvai AE
Mod Pathol; 2014 Jan; 27(1):55-61. PubMed ID: 23929265
[TBL] [Abstract][Full Text] [Related]
15. SOX10 immunohistochemistry in sweat ductal/glandular neoplasms.
Cassarino DS; Su A; Robbins BA; Altree-Tacha D; Ra S
J Cutan Pathol; 2017 Jun; 44(6):544-547. PubMed ID: 28343365
[TBL] [Abstract][Full Text] [Related]
16. SOX10 expression in malignant melanoma, carcinoma, and normal tissues.
Mohamed A; Gonzalez RS; Lawson D; Wang J; Cohen C
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):506-10. PubMed ID: 23197006
[TBL] [Abstract][Full Text] [Related]
17. SOX10 and Olig2 as negative markers for the diagnosis of ependymomas: An immunohistochemical study of 98 glial tumors.
Švajdler M; Rychlý B; Mezencev R; Fröhlichová L; Bednárová A; Pataky F; Daum O
Histol Histopathol; 2016 Jan; 31(1):95-102. PubMed ID: 26287936
[TBL] [Abstract][Full Text] [Related]
18. Sox10 expression in ovarian epithelial tumors is associated with poor overall survival.
Kwon AY; Heo I; Lee HJ; Kim G; Kang H; Heo JH; Kim TH; An HJ
Virchows Arch; 2016 May; 468(5):597-605. PubMed ID: 26951260
[TBL] [Abstract][Full Text] [Related]
19. Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: An Immunohistochemical Study of 5229 Cases.
Miettinen M; Wang Z; Lasota J; Heery C; Schlom J; Palena C
Am J Surg Pathol; 2015 Oct; 39(10):1305-12. PubMed ID: 26099010
[TBL] [Abstract][Full Text] [Related]
20. Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation.
Gershon TR; Oppenheimer O; Chin SS; Gerald WL
Neoplasia; 2005 Jun; 7(6):575-84. PubMed ID: 16036108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]